Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
30.05. | Nuformix PLC - Total Voting Rights | - | RNS | ||
NUFORMIX Aktie jetzt für 0€ handeln | |||||
29.05. | Nuformix PLC - Confirmation of European ODD for NXP002 | - | RNS | ||
23.05. | Nuformix PLC - Publication of a Prospectus | 1 | RNS | ||
22.05. | Nuformix PLC - £210,000 Placing | - | RNS | ||
19.05. | Nuformix PLC - Attendance at American Thoracic Society Congress | - | RNS | ||
02.05. | Nuformix interim loss widens as focused on advancing assets | 1 | Alliance News | ||
02.05. | Nuformix PLC - Half-year Report | - | RNS | ||
30.04. | Nuformix PLC - Confirmation of European Orphan Drug Designation | - | RNS | ||
14.04. | Nuformix PLC - Correction - Exercise of Warrants | - | RNS | ||
14.04. | Nuformix PLC - Exercise of Warrants | - | RNS | ||
09.04. | Nuformix PLC - NXP002 Update | - | RNS | ||
20.03. | Nuformix PLC - Result of AGM | 1 | RNS | ||
28.02. | Nuformix PLC - Total Voting Rights | - | RNS | ||
14.02. | Nuformix PLC - Posting of Annual Report and Notice of AGM | - | RNS | ||
30.01. | Nuformix PLC - £168,750 Placing | - | RNS | ||
29.01. | EARNINGS AND TRADING: S-Ventures loss narrows; charge knocks Nuformix | 1 | Alliance News | ||
29.01. | Nuformix PLC - Annual Results for period ended 30 September 2024 | - | RNS | ||
28.01. | Nuformix PLC - NXP002 ODD Application Submitted | 4 | RNS | ||
13.01. | Nuformix PLC - NXP002 Orphan Drug Designation Draft Application | 1 | RNS | ||
04.11.24 | XFRA CAPITAL ADJUSTMENT INFORMATION - 04.11.2024 | 1.329 | Xetra Newsboard | Das Instrument S9K KYG7783W1006 SAMSON HOLDING LTD DL-,05 EQUITY wird cum Kapitalmassnahme gehandelt am 04.11.2024 und ex Kapitalmassnahme am 05.11.2024 The instrument S9K KYG7783W1006 SAMSON HOLDING... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
HALO COLLECTIVE | 0,010 | 0,00 % | Waters Corporation Buys Halo Labs | WASHINGTON (dpa-AFX) - Waters Corporation (WAT), an analytical instruments and software firm, said on Wednesday that it has acquired Halo Labs, a company focused on specialized imaging technologies... ► Artikel lesen | |
BIONANO GENOMICS | 3,260 | -0,91 % | Bionano Genomics: Bionano Reports First Quarter 2025 Results and Highlights Recent Business Progress | SAN DIEGO, May 14, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today reported financial results for the first quarter ended March 31, 2025. "The first quarter of 2025 represents... ► Artikel lesen | |
TONIX PHARMACEUTICALS | 29,000 | -2,68 % | Pre-market Movers: Creative Global Technology, Liminatus Pharma, CureVac, Jupiter Neurosciences, Tonix Pharmaceuticals | BEIJING (dpa-AFX) - The following are some of the stocks making big moves in Thursday's pre-market trading (as of 08.05 A.M. ET).In the Green Creative Global Technology Holdings Limited (CGTL)... ► Artikel lesen | |
JAGUAR HEALTH | 2,500 | -7,75 % | Jaguar Health, Inc.: Jaguar Health Board of Directors Authorizes Company to Include Cryptocurrency as a Treasury Reserve Asset | Strategic decision positions Jaguar to diversify treasury holdings with a long-term digital store of value SAN FRANCISCO, CA / ACCESS Newswire / June 26, 2025 / Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar"... ► Artikel lesen | |
ARGENT BIOPHARMA | 0,043 | -1,15 % | Argent BioPharma Ltd. Updates on SINTEF Collaboration for Chronic Wound Management | Advanced wound care market projected to exceed $15 billion globally by 2030
PERTH, Australia, Feb. 12, 2025 /PRNewswire/ -- Argent BioPharma Ltd. (ASX: RGT)... ► Artikel lesen | |
BIODEXA PHARMACEUTICALS | 0,876 | -4,99 % | Biodexa Pharmaceuticals PLC: Results of Annual General Meeting | June 27, 2023 Biodexa Pharmaceuticals PLC ("Biodexa" or the "Company") Results of Annual General Meeting Biodexa Pharmaceuticals PLC (NASDAQ: BDRX), a clinical stage biopharmaceutical company developing... ► Artikel lesen | |
CITIUS PHARMACEUTICALS | 1,530 | +15,04 % | Citius Pharmaceuticals, Inc. Reports Fiscal Second Quarter 2025 Financial Results and Provides Business Update | CRANFORD, N.J., May 14, 2025 /PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius Pharma" or the "Company") (Nasdaq: CTXR), a biopharmaceutical company dedicated... ► Artikel lesen | |
GRACE THERAPEUTICS | 2,950 | +0,34 % | Grace Therapeutics, Inc.: Grace Therapeutics Announces Submission of New Drug Application to U.S. Food and Drug Administration for GTx-104 | Submission Seeks Approval of GTx-104 in the Treatment of Patients with aneurysmal Subarachnoid Hemorrhage (aSAH) Comprehensive Data Package Includes Positive Results from Phase 3 STRIVE-ON Safety... ► Artikel lesen | |
BAYER | 26,975 | +2,64 % | EQS-PVR: Bayer Aktiengesellschaft: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung | EQS Stimmrechtsmitteilung: Bayer Aktiengesellschaft
Bayer Aktiengesellschaft: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung
23.06.2025... ► Artikel lesen | |
MERCK KGAA | 112,65 | +0,90 % | MilliporeSigma and "Abbott Elementary" Inspire Students' Curiosity With Hands-On STEM | NORTHAMPTON, MA / ACCESS Newswire / June 25, 2025 / Between September 2024 and April 2025, MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, teamed up with... ► Artikel lesen | |
NOVO NORDISK | 58,70 | +0,09 % | Novo Nordisk-Aktie: Geht es noch tiefer? | Die Aktie von Novo Nordisk hat nach ihrem monatelangen Abwärtstrend eine Erholung gezeigt, doch jetzt sieht es danach aus, als würde es erneut mit den Papieren nach unten gehen. Doch was steckt dahinter?... ► Artikel lesen | |
PFIZER | 20,665 | +0,02 % | Depot Verdoppler mit Künstlicher Intelligenz: Novo Nordisk, PanGenomic Health und Pfizer zünden 2025 den Profit-Turbo | Lauf BlackRock Health Sciences steht der globale Gesundheitssektor 2025 vor einem beispiellosen Aufschwung. Nach Jahren der Volatilität durch die Pandemie soll die Branche jetzt die höchsten Gewinnzuwächse... ► Artikel lesen | |
EYENOVIA | 10,960 | +38,91 % | Eyenovia launches validator node for Hyperliquid blockchain | ||
ROCKET LAB | 30,200 | -0,10 % | Rocket Lab Corporation: Rocket Lab to Launch Electron Mission for European Space Agency's Next-Generation Navigation System | Rocket Lab Corporation (Nasdaq: RKLB) ("Rocket Lab" or the "Company"), a global leader in launch services and space systems, today announced it has been selected to launch a dedicated Electron mission... ► Artikel lesen | |
ASTRAZENECA | 120,05 | +0,42 % | JPMORGAN stuft ASTRAZENECA auf 'Overweight' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Einstufung für Astrazeneca mit einem Kursziel von 14000 Pence auf "Overweight" belassen. Die beschleunigte US-Zulassung von Datroway gegen... ► Artikel lesen |